Journal of Evolving Stem Cell Research

Submit Manuscript

Journal of Evolving Stem Cell Research · ISSN 2574-4372 · Open Access Pub

Instructions for Authors

What a manuscript must contain, how it should be prepared, and how to send it. Requirements specific to stem cell research — cell provenance, authentication and characterization — are set out alongside the general ones.

Before you write

Requirements by article type

Each format carries its own limits. Word counts exclude the abstract, references, tables and figure legends.

Original Research
Full-length investigations presenting new findings.
  • Up to 6,000 words
  • Structured abstract, up to 300 words
  • Up to 60 references
  • 4–6 keywords
The abstract is structured as background, methods, results and conclusions.
Technical Advances
New methods, protocols or technologies that extend what can be measured or made.
  • Up to 4,000 words
  • Up to 40 references
  • 4–6 keywords
Methodology must be reported in enough detail for another laboratory to reproduce the procedure.
Review Articles
Analyses that synthesize a body of published work.
  • Up to 8,000 words
  • Up to 100 references
  • 4–6 keywords
Systematic reviews follow PRISMA and include the completed checklist.
Clinical Studies
Translational and clinical work with cell-based approaches.
  • Up to 5,000 words
  • Up to 50 references
  • 4–6 keywords
Interventional trials must report the registry name, registration number and registration date.

Authors who wish to propose a format other than these are invited to write to the editorial office before submitting, so that the appropriate requirements can be agreed in advance.

Manuscript structure

How to organize the paper

Sections in order

  • Title page. Title of up to 150 characters, all author names and affiliations, corresponding author contact, word count and conflict disclosures.
  • Abstract. Structured as background, methods, results and conclusions, with 4–6 keywords.
  • Introduction. Background, the rationale for the question, and the objectives of the study.
  • Methods. Detailed enough to enable replication, including cell sources, culture conditions and analysis.
  • Results. The findings, organized logically, with supporting tables and figures and without interpretation.
  • Discussion. Interpretation, comparison with existing literature, and the limitations of the design and system used.
  • References. Vancouver format throughout.

Files and formatting

  • Document. Microsoft Word, double spaced, 12-point Times New Roman, 2.5 cm margins, pages numbered consecutively.
  • Figures. Separate files in TIFF, JPEG or EPS at a minimum of 300 dpi. Microscopy images require scale bars.
  • Tables. Editable format with clear headings and explanatory footnotes, not duplicating data given in the text or figures.
  • Supplementary material. Additional data, protocols or supporting analyses in clearly labeled files.
  • Data availability. Every empirical research manuscript must include a data-availability statement.

Specific to this field

Reporting the cells themselves

A stem cell result is only interpretable if the reader knows what the cells were and how they were kept. These requirements apply to every manuscript in which cells are used.

  • Describe cell line sources and provenance, and the authentication methods used.
  • Confirm mycoplasma testing.
  • State passage number and the culture conditions under which the reported work was done.
  • Report the characterization supporting any claim about identity, potency or differentiated state.
  • Report the ethical approvals for human-derived materials.
  • Novel cell lines should be made available to qualified researchers.

Approvals and disclosure

Ethical requirements

  • Institutional review board or ethics committee approval is required for research involving human materials.
  • Informed consent documentation is required for patient-derived samples and for the generation of induced pluripotent stem cells.
  • Research involving human embryonic stem cells must comply with ISSCR guidance and with the applicable national and international guidelines.
  • Conflicts of interest must be disclosed in full, including industry relationships, together with funding sources and the role of the funder.
  • Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.

Reporting guidelines by design: ARRIVE for animal studies, CONSORT for randomized trials, PRISMA for systematic reviews and meta-analyses, MIAME for microarray and gene-expression studies, and MIQE for quantitative PCR. Supply the completed checklist for the guideline that applies.

Review preparation

If you request double-blind review

Single-blind by default; double-blind review is available on request. For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.

Sending the manuscript

Submission

After submission

What happens next

All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts. An article processing charge is invoiced only after acceptance.

Menu